Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia

Clinical impact of c-KIT and CEBPA mutations in 33 patients with corebinding factor (Non-M3) acute myeloid leukemia

Background: Corebinding factor acute myeloid leukemia (CBF-AML) is the most common cytogenetic subtype of pediatric AML. CBF-AML is associated with a relatively favorable outcome, although the relapse rate of approximately 40% indicates a high degree of clinical heterogeneity. The clinical impact of...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyan Mao, Runxiu Yin, Li Liu, Yan Zhou, Chunhui Yang, Chunlian Fang, Hongchao Jiang, Qulian Guo, Xin Tian
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Pediatrics and Neonatology
Subjects:
c-KIT
CBF-AML
CEBPA
Pediatric
Prognosis
Online Access:http://www.sciencedirect.com/science/article/pii/S1875957223000190
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items